The global Medical Topical Hemostatic Agent market size is predicted to grow from US$ 9313 million in 2025 to US$ 14270 million in 2031; it is expected to grow at a CAGR of 7.4% from 2025 to 2031.

Medical topical hemostatic agent are used in the setting of surgery or trauma as adjuncts to maintain hemostasis. Topical hemostat products include gelatin sponges, collagens, fibrin sealants, and active thrombin preparations. These agents are applied locally to stop blood flow.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Infinity Market Research newest research report, the Medical Topical Hemostatic Agent Industry Forecast looks at past sales and reviews total world Medical Topical Hemostatic Agent sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Topical Hemostatic Agent sales for 2025 through 2031. With Medical Topical Hemostatic Agent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Topical Hemostatic Agent industry.

This Insight Report provides a comprehensive analysis of the global Medical Topical Hemostatic Agent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Topical Hemostatic Agent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Medical Topical Hemostatic Agent market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Topical Hemostatic Agent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Topical Hemostatic Agent.

This report presents a comprehensive overview, market shares, and growth opportunities of Medical Topical Hemostatic Agent market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Gelation Sponge
    Oxidized Regenerated Cellulose Based Hemostats
    Others

Segmentation by Application:

    Hospitals
    Surgical Centers
    Nursing Homes

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Ethicon
    Pfizer
    Baxter International
    C. R. Bard
    The Medicines Company
    Anika Therapeutics
    Advanced Medical Solutions
    Integra LifeSciences
    B Braun Melsungen
    Gelita Medical
    Equimedical
    Vascular Solutions
    Marine Polymer Technologies

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Topical Hemostatic Agent market?
What factors are driving Medical Topical Hemostatic Agent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Topical Hemostatic Agent market opportunities vary by end market size?
How does Medical Topical Hemostatic Agent break out by Type, by Application?